Earnings History Data for Stealth BioTherapeutics Corp. (MITO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Stealth BioTherapeutics Corp.

Stealth BioTherapeutics Corp is a biopharmaceutical company. It is engaged in developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases. The company's product pipeline includes Elamipretide, SBT-20 and SBT-272 which are in clinical stage. Stealth BioTherapeutics Corp is based in Newton, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-11-2021	PM	7:30 AM ET (Nov 11)	MITO	Stealth BioTherapeutics Corp.	62.19	-0.02	-0.02	-0.02	Stealth BioTherapeutics EPS beats by $0.01 [11/11/2021 7:35 AM]	1.03	-0.02 (-1.90%)	1.06	0.01 (0.95%)	1.01 - 2.58	154,080	240,000	8,771
Stealth BioTherapeutics EPS beats by $0.01 [11/11/2021 7:35 AM] Stealth BioTherapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights [Nov-11-21 07:30AM]
05-08-2021	PM	7:30 AM ET (Aug 5)	MITO	Stealth BioTherapeutics Corp.	78.72	-0.03	-0.02	-0.02	Stealth BioTherapeutics EPS misses by $0.01 [8/5/2021 7:55 AM]	1.31	-0.07 (-5.07%)	1.36	-0.02 (-1.45%)	1.06 - 2.58	275,570	100,000	4,155
Stealth BioTherapeutics EPS misses by $0.01 [8/5/2021 7:55 AM] Stealth BioTherapeutics Reports Second Quarter 2021 Financial Results And Recent Business Highlights [Aug-05-21 07:30AM]
18-05-2021	PM	7:30 AM ET (May 18)	MITO	Stealth BioTherapeutics Corp.	65.63	-0.01	-0.02	-0.04	Stealth BioTherapeutics EPS in-line [5/18/2021 7:36 AM]	1.39	0.20 (16.81%)	1.53	0.34 (28.57%)	1.06 - 2.58	39,101,267	22,250,000	5,947,422
Stealth BioTherapeutics EPS in-line [5/18/2021 7:36 AM] Stealth BioTherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials [May-17-21 05:00PM] Stealth BioTherapeutics Announces Poster Presentation at American College of Cardiology (ACC) Annual Meeting [May-17-21 07:30AM] Stealth BioTherapeutics Corp. to Host Earnings Call [May-18-21 06:45AM] Stealth BioTherapeutics Reports First Quarter 2021 Financial Results And Recent Business Highlights [May-18-21 07:30AM] Stealth BioTherapeutics Stock Surges On $30M Funding To Advance Elamipretide Development [May-18-21 06:21AM]
06-04-2021	PM	7:30 AM ET (Apr 6)	MITO	Stealth Biotherapeutics Corp. Sponsored Adr	86.00	-0.36	-0.02	0.00	Stealth BioTherapeutics EPS misses by $0.08 [4/6/2021 7:48 AM]	1.45	-0.22 (-13.10%)	1.60	-0.07 (-4.19%)	1.19 - 2.58	424,256	110,000	18,683
Stealth BioTherapeutics EPS misses by $0.08 [4/6/2021 7:48 AM] Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights [Apr-06-21 07:30AM] Stealth BioTherapeutics Corp. to Host Earnings Call [Apr-06-21 06:30AM]
05-11-2020	PM		MITO	Stealth BioTherapeutics Corp.	69.93	-0.02	-0.02	-0.04	Stealth BioTherapeutics EPS in-line [11/5/2020 7:50 AM]	1.34	-0.05 (-3.60%)	1.44	0.05 (3.60%)	0.90 - 14.41	170,540	60,005	27,388

06-08-2020	PM	7:30 AM ET (Aug 6)	MITO	Stealth BioTherapeutics Corp.	103.56	-0.02	-0.02	-0.04	Stealth BioTherapeutics EPS beats by $0.01 [8/6/2020 7:46 AM]	1.96	-0.06 (-2.82%)	2.05	0.03 (1.64%)	0.90 - 14.41	280,267	457,786	4,067